Cross-Listed International Stocks: Another Investing Alternative
February 15, 2012
Key Points
- In previous articles, we've discussed three ways to invest in international stocks—here, we'll discuss a fourth alternative that may provide benefits the other methods can't.
- Cross-listed stocks trade on one or more foreign stock exchanges in addition to their domestic exchanges, which helps improve liquidity and can potentially improve the quality of information about the issuer.
- From a trade-execution standpoint, there are some benefits to buying a cross-listed stock on a national exchange.
If you're only investing in the stocks of US companies, you may be missing opportunities to grow your portfolio. Not only are you excluding three-fourths of the global economy, you could be missing the potential for higher rates of growth abroad, the potential to lower overall risk in your portfolio and potential currency diversification as well.
In earlier articles about how to invest in international stocks, John Wightkin described three primary methods: purchasing ordinary common shares directly in their primary foreign market, purchasing American Depositary Receipts (ADRs) on a US exchange or the over-the-counter market, or purchasing foreign stocks via the US OTC market.
But there's a fourth alternative: purchasing cross-listed international stocks, which are listed on one or more foreign stock exchanges in addition to their domestic exchanges. These stocks may provide certain trade-execution benefits that can't always be obtained through the trading channels mentioned above. Currently, these opportunities are generally limited to Canadian stocks, but stocks from more countries may be cross-listed in the future.
Cross-listed stocks differ from ADRs and other depositary-receipt securities (e.g. European Depositary Receipts and Global Depositary Receipts) in that they don't involve the creation of a depositary relationship by a third party. Instead, the company lists its common shares directly on a US (or other) exchange as well as its domestic exchange. Cross-listed stocks that trade on the New York Stock Exchange (NYSE), the NYSE AMEX (formerly the American Stock Exchange) and the NASDAQ Global Market System (NASDAQ GMS) also differ from those traded in the OTC market, for reasons I'll explain below.
Blue skies and stock exchanges
Securities traded on US markets are generally subject to stringent registration requirements imposed by regulatory agencies and organizations like the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority.
One category of registration requirements, known as "blue-sky laws," regulates the offering and trading of stocks. These laws were originally passed by state legislatures in an effort to help protect investors against fraud. Because blue-sky laws apply at the state level, a security that isn't registered in all states must trade in the OTC market. The security can't be sold in a particular state unless the security is registered under the blue-sky laws of that state.
But stocks meeting the listing requirements of the NYSE, NYSE AMEX or NASDAQ GMS are considered to have met the blue-sky laws of all 50 US states and US territories by virtue of their registration on those exchanges. As a result, securities traded on those markets may be sold anywhere in the United States.
Approximately 100 Canadian stocks are listed on the Toronto Stock Exchange (TSE) and the NYSE, NYSE AMEX or NASDAQ GMS. As an example, let's look at Canadian National Railway Company (ticker CNI, NYSE). Clients can log in to our Stocks Research page and enter CNI's ticker symbol in the box at the top, you'll see the Stock Summary page for the stock. CNI's stock is rated relative to other Canadian stocks by Schwab Equity Ratings International (as shown by the statement "Within the Country of Canada"), but note that it trades on the NYSE as well as the Toronto Stock Exchange.

Source: www.schwab.com, as of February 8, 2012.
The rationale for cross-listing
Listing a company's stock on a national exchange like the NYSE can be a significant effort1. Not only does a company need to meet requirements regarding the number of shareholders, shares outstanding, market capitalization, minimum price and certain financial criteria specified by the exchange, but it must file its financial statements and other documents with the SEC and abide by the provisions of a number of other US regulations, including the Sarbanes-Oxley Act ("SarbOx").
So why would an international company choose to cross-list its shares? And is there any benefit to US investors as a result?
Academic researchers have identified a number of possible motives for cross-listing2. Three of the major ones are:
- Improved liquidity: A listing on a more-liquid stock market can potentially increase a stock's liquidity, seeking to reduce the issuing company's financing costs. Plus, having shares trade in multiple time zones and currencies provides issuing companies more liquidity and an increased ability to raise capital.
- Information quality: A firm's willingness to cross-list its stock on a market with stringent disclosure requirements and strong investor-protection laws can provide outside investors with information they may need to determine the quality of the firm's accounting information and financial statements (for example, by reconciling its financial results to US generally accepted accounting principles).
- Investor protection: This motivation, described in academic research as "bonding," is based on the idea that registration on a US exchange acts as a mechanism that voluntarily commits the firm to a higher standard of corporate governance and investor protection, as exemplified by SarbOx. Bonding therefore might make firms attractive to risk-averse investors who might otherwise be reluctant to invest.
Motivations that affect firms may also represent potential benefit to investors, though evidence that quantifies those benefits is mixed. But from a trade-execution standpoint, there are some benefits to buying a cross-listed stock on a national exchange.
The fact that a stock is quoted in US dollars means that it's not necessary to convert a foreign currency price quote to US dollars. A number of order types, including stop and stop-limit orders which can be used to set buy or sell prices for stocks, are accepted for cross-listed stocks, but not for OTC stocks or ADRs traded in the OTC market. ADR holders must also pay annual custody fees to the financial institution that establishes the ADR, while cross-listed securities are not subject to such fees.
Dividends are paid in US dollars, rather than the foreign currency. (At Schwab, transactions conducted on US exchanges are settled through the Depository Trust and Clearing Corporation, which handles currency conversions for dividends. Transactions conducted by Schwab clients on foreign exchanges are settled through Citigroup, which does not convert foreign currency-denominated dividends.) Dividend reinvestment, however, is not available for cross-listed stocks.
Note that the US and Canadian shares are not "fungible"—buying a cross-listed stock requires that you hold the stock in US dollars and receive US dollar-denominated dividends. In addition, the US and Canadian prices of cross-listed stocks tend to move very closely together.
Conclusion
Purchasing cross-listed stocks represents a fourth method for Schwab clients to consider when investing internationally. While generally limited to Canadian stocks, as mentioned previously, cross-listing allows Schwab investors to utilize the power of Schwab Equity Ratings International to select stocks while simultaneously allowing them to invest in a low-cost, flexible way.
The tax implications for buying cross-listed stocks are the same as an ADR, OTC or a foreign ordinary. If you pay tax in a foreign jurisdiction, you get a tax credit against your US tax bill. Regarding trading costs, OTC trades at Schwab (whether involving common foreign shares or an ADR) involve a $50 foreign transaction fee on top of the regular commission—a fee that can be avoided when buying a cross-listed stock. (For more information, see Schwab's Fees and Minimums, where you can find the latest Charles Schwab Pricing Guide.)
In order to find cross-listed Canadian stocks, use the International Stock Screener to screen for A- and B-rated stocks in Canada. When viewing the results, make a note of the name of any company that's rated but does not display an OTC or ADR symbol. Then use the Research tab to enter the company name, and look for the Schwab Equity Ratings International letter grade in the blue diamond shape and the "Within the Country of Canada" note near the grade.
1. See the full New York Stock Exchange standards at: usequities.nyx.com/regulation/listed-companies-compliance/listings-standards/us.
2. Pamela C. Moulton, Li Wei, "A Tale of Two Time Zones: The Impact of Substitutes on Cross-Listed Stock Liquidity," Journal of Financial Markets, Vol. 12, November 4, 2009.
Important Disclosures
International investments involve additional risks, which include differences in financial accounting standards, currency fluctuations, political instability, foreign taxes and regulations, and the potential for illiquid markets. Investing in emerging markets may accentuate these risks.
Schwab Equity Ratings International are assigned to the stocks of approximately 4,000 foreign companies headquartered and trading in certain foreign countries. The rating for a foreign stock also applies to US-traded ADRs and/or OTC stocks of the same company. Schwab's research outlook is that A-rated stocks, on average, will strongly outperform, and F-rated stocks, on average, will strongly underperform the foreign equities market on which the stock is traded or in which the company is headquartered during the next 12 months.
Schwab Equity Ratings International and the general buy/hold/sell guidance are not personal recommendations for any particular investor or client and do not take into account the financial, investment or other objectives or needs of, and may not be suitable for, any particular investor or client. Investors and clients should consider Schwab Equity Ratings International as only a single factor in making their investment decision while taking into account the current market environment.
This information is not intended to be a substitute for specific individualized tax, legal or investment planning advice. Where specific advice is necessary or appropriate, Schwab recommends consultation with a qualified tax advisor, CPA, Financial Planner or Investment Manager.
The information provided here is for general informational purposes only and should not be considered an individualized recommendation or personalized investment advice. The investment strategies mentioned here may not be suitable for everyone. Each investor needs to review an investment strategy for his or her own particular situation before making any investment decision.
All expressions of opinion are subject to change without notice in reaction to shifting market conditions. Data contained herein from third-party providers is obtained from what are considered reliable sources. However, its accuracy, completeness or reliability cannot be guaranteed.
Examples provided are for illustrative purposes only and not intended to be reflective of results you can expect to achieve.
Diversification strategies do not assure a profit and do not protect against losses in declining markets.
The Schwab Center for Financial Research is a division of Charles Schwab & Co., Inc.
